- Home
- SVRA vs WLTH Comparison
SVRA vs WLTH Comparison
Compare SVRA & WLTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | SVRA | WLTH |
|---|---|---|
| Founded | 2007 | 2008 |
| Country | United States | United States |
| Employees | N/A | 391 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 2009 | N/A |
Fundamental Metrics
Financial Performance| Metric | SVRA | WLTH |
|---|---|---|
| Price | $5.51 | $8.88 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 8 |
| Target Price | $7.33 | ★ $12.86 |
| AVG Volume (30 Days) | ★ 2.0M | 1.3M |
| Earning Date | 05-13-2026 | 05-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $10.58 |
| Revenue Next Year | $430.87 | $23.43 |
| P/E Ratio | ★ N/A | $10.57 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $2.43 | $7.20 |
| 52 Week High | $7.01 | $14.12 |
Technical Indicators
Market Signals| Indicator | SVRA | WLTH |
|---|---|---|
| Relative Strength Index (RSI) | 44.29 | 43.75 |
| Support Level | $5.32 | $8.57 |
| Resistance Level | $6.15 | $9.32 |
| Average True Range (ATR) | 0.30 | 0.34 |
| MACD | -0.07 | 0.03 |
| Stochastic Oscillator | 9.72 | 32.57 |
Price Performance
Historical ComparisonAbout SVRA Savara Inc.
Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).
About WLTH Wealthfront Corporation Common Stock
Wealthfront Corp is a product-driven technology company that built a financial solutions platform for digital natives. The platform is designed to address the needs of the wealth builders within these generations. Its business model is designed to optimize for clients' success. The focus on delivering fully automated services results in being one of the lowest cost producers in each category in which participate. The group generates revenue from cash management and investment advisory products. Cash management revenue is earned from fees received for the delivery of cash management services, including the cash sweep program.